Korro Bio (KRRO) EBIT (2019 - 2025)
Historic EBIT for Korro Bio (KRRO) over the last 7 years, with Q3 2025 value amounting to -$19.2 million.
- Korro Bio's EBIT rose 1740.94% to -$19.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$94.5 million, marking a year-over-year increase of 131.99%. This contributed to the annual value of -$91.9 million for FY2024, which is 872.55% down from last year.
- Korro Bio's EBIT amounted to -$19.2 million in Q3 2025, which was up 1740.94% from -$27.2 million recorded in Q2 2025.
- In the past 5 years, Korro Bio's EBIT ranged from a high of $5.8 million in Q4 2022 and a low of -$27.2 million during Q2 2025
- Its 5-year average for EBIT is -$20.6 million, with a median of -$21.4 million in 2021.
- As far as peak fluctuations go, Korro Bio's EBIT soared by 12719.23% in 2022, and later plummeted by 56303.37% in 2023.
- Korro Bio's EBIT (Quarter) stood at -$21.4 million in 2021, then surged by 127.19% to $5.8 million in 2022, then crashed by 563.03% to -$26.9 million in 2023, then grew by 14.33% to -$23.0 million in 2024, then rose by 16.51% to -$19.2 million in 2025.
- Its EBIT was -$19.2 million in Q3 2025, compared to -$27.2 million in Q2 2025 and -$25.0 million in Q1 2025.